Biomerica provides update on inFoods® IBS expansion
April 15, 2024 07:47 ET | Biomerica, Inc.
- Expansion into new offices within current major groups, including Northeast and Ohio; Expansion into new major group in Texas. - Average quarterly increase in physicians prescribing inFoods more...
Biomerica Expands inFoods IBS Reach with Addition of Several New GI Groups
November 08, 2023 08:19 ET | Biomerica, Inc.
Biomerica remains on track for inFoods® IBS national rollout during calendar 2024, and expects strong product revenue growth during national rolloutVeteran Vice President of Sales and National...
Taurex en Rankia Markets Experience: Una Destacada Participación en América Latina
November 01, 2023 15:30 ET | Taurex
BOGOTÁ, Colombia, Nov. 01, 2023 (GLOBE NEWSWIRE) -- En octubre de 2023, Taurex, un broker regulado que recientemente experimentó una renovación de marca, dejó una impresión significativa en el...
Taurex’s Remarkable Impact at Rankia Markets Experience in Latin America
November 01, 2023 15:30 ET | Taurex
The event featured a lineup of high-value conferences and networking opportunities, covering topics such as financial markets, technical analysis, trading.
Diagnostics Industry Leader Jack Kenny Joins Biomerica’s Board of Directors
August 28, 2023 08:19 ET | Biomerica, Inc.
Kenny has proven track record of driving growth at companies within the healthcare space and holds significant management and public company board experience, most recently as CEO of Meridian...
Panacea Life Sciences Holdings, Inc. Announces CBD/CBG Clinical Trial Findings for the Management of Irritable Bowel Symptoms
July 20, 2023 09:15 ET | Panacea Life Sciences Holdings, Inc.
GOLDEN, Colo., July 20, 2023 (GLOBE NEWSWIRE) -- Panacea Life Sciences Holdings, Inc. (OTCQB:PLSH) (“Panacea” or the “Company”), a plant-based natural health and wellness company, today announced it...
Global Market for Constipation Treatment
Global Constipation Treatment Market Report 2023-2030 - Lucrative Opportunities in China as the Chinese Market is Forecast to Grow at 9% CAGR
June 23, 2023 04:23 ET | Research and Markets
Dublin, June 23, 2023 (GLOBE NEWSWIRE) -- The "Constipation Treatment: Global Strategic Business Report" report has been added to's offering.Global Constipation Treatment...
Biomerica’s inFoods® IBS test is now available at Gastro Health, providing a revolutionary new treatment for patients suffering from Irritable Bowel Syndrome (IBS).
April 17, 2023 07:47 ET | Biomerica, Inc.
Gastro Health is a leading gastroenterology group with over 380 GI physicians in the United StatesClinical study results show patients who eliminated foods as determined by the inFoods® IBS test...
Biomerica InFoods® IBS Data Presented at the 2022 American College of Gastroenterology (ACG) Annual Scientific Meeting
November 02, 2022 08:19 ET | Biomerica, Inc.
ACG Presidential Award Received for the InFoods® IBS Data Presented at the American College of Gastroenterology (ACG) Annual Scientific MeetingThe Presented Clinical Study Data Showed InFoods® IBS...
metaMe Health partners with Launchit Ventures to market Regulora, an FDA-cleared Prescription Digital Therapeutic for adults with IBS, in Canada
September 29, 2022 09:00 ET | metaMe Health, Inc.
HAMILTON, Ontario and CHICAGO, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Launchit Ventures, Inc., a HealthTech solutions provider and global commercialization partner developing new technology-led business...